Postdoc: Medical Radionuclide Therapy with 211At

The University of Oslo is looking for a Postdoctoral Research Fellow in Medical Applications of Radionuclides. This position is focused on developing targeted alpha therapy using 211At within the Nuclear Chemistry group.

Applicants should hold a PhD in relevant fields, with a strong background in radionuclide production. The fellowship lasts for three years, offering ample opportunities for collaboration with national and international partners as well as career development support.